Results 111 to 120 of about 226,280 (311)

Elimination of visceral leishmaniasis in Ethiopia: cross-sector collaboration and cost sharing to promote sustainability

open access: yesInternational Journal of Infectious Diseases
Objectives: Sustainable elimination of visceral leishmaniasis as a public health problem requires the contribution of various stakeholders led by the governments.
Duncan Ochol   +4 more
doaj   +1 more source

The use of K39 test in the diagnosis of visceral leishmaniasis [PDF]

open access: yes, 2007
From time to time patients admitted with fever of unknown origin prove to be a diagnostic dilemma. While textbooks describe typical symptoms and signs, and also diagnostic tests, these are not always helpful.
Sciberras, Robert
core  

Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection [PDF]

open access: yes, 2014
Background/Purpose: A proper adjuvant has a relevant role in vaccine formulations to generate an effective immune response. In this study, total Leishmania antigen (TLA) formulated with Montanide ISA 763 or R848 as adjuvants were evaluated as a first ...
Cargnelutti, Diego Esteban   +6 more
core   +1 more source

Hidden in Plain Sight: The Enduring Challenge of Neglected Tropical Diseases in Khartoum State, Sudan

open access: yesJournal of Tropical Medicine, Volume 2026, Issue 1, 2026.
Background Neglected tropical diseases (NTDs) disproportionately affect impoverished populations in tropical regions. Despite their significant health burden, data on NTD prevalence and distribution are limited in many areas, including Khartoum State, Sudan.
Babiker Mohamed Rahamtalla   +1 more
wiley   +1 more source

New Se‐Compounds With Antileishmanial, Antitumor, and Carbonic Anhydrase Inhibitory Properties

open access: yesArchiv der Pharmazie, Volume 358, Issue 12, December 2025.
A small library of selenocompounds was evaluated for their antileishmanial, antitumoral, and human carbonic anhydrase (hCA) inhibitory properties. Two trifluoromethoxy‐substituted anilide derivatives (3 and 6) were the most effective ones against Leishmania major (L. major) and Leishmania infantum (L. infantum) promastigotes and also showed a promising
Cristina Morán‐Serradilla   +5 more
wiley   +1 more source

Autochthonous Outbreak and Expansion of Canine Visceral Leishmaniasis, Uruguay

open access: yesEmerging Infectious Diseases, 2017
We report an outbreak of canine visceral leishmaniasis in Uruguay. Blood specimens from 11/45 dogs tested positive for Leishmania spp. Specimens of Lutzomyia longipalpis sand flies were captured; typing revealed Leishmania infantum. Our findings document
D. Satragno   +9 more
semanticscholar   +1 more source

Is Visceral Leishmaniasis the same in HIV-coinfected adults?

open access: yesBrazilian Journal of Infectious Diseases, 2018
Introduction: Visceral Leishmaniasis is the most severe form of disease caused by the Leishmania donovani complex, with significant morbidity and mortality in developing countries.
Guilherme Alves de Lima Henn   +7 more
doaj   +1 more source

THE INVESTIGATION OFANTI NUCLEAR ANTI BODY (ANA) IN VISCERAL LEISHMANIASIS IN ARDABIL IN 1384-1385 [PDF]

open access: yes
Introduction: The ANA test is a blood test that is commonly used for evaluating of autoimmune or connective tissue disorders.The ANA test identifies auto antibodies that target the nucleus of cells.
صالح زاده, فرهاد   +2 more
core  

Leishmaniasis in rheumatoid arthritis

open access: yesReumatismo, 2011
Leishmaniasis represents a complex of diseases with an important clinical and epidemiological diversity. Visceral leishmaniasis is of higher priority than cutaneous leishmaniasis as it is a fatal disease in the absence of treatment. The clinical spectrum
M. Cutolo, M.E. Secchi, C. Pizzorni
doaj   +1 more source

Natural history of a visceral leishmaniasis outbreak in highland Ethiopia [PDF]

open access: yes, 2009
In May 2005, visceral leishmaniasis (VL) was recognized for the first time in Libo Kemken, Ethiopia, a highland region where only few cases had been reported before. We analyzed records of VL patients treated from May 25, 2005 to December 13, 2007 by the
Alvar, J   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy